BridgeBio Oncology Therapeutics, Inc. BBOT
2.32 USD +0.01 (+0.43%)
At closeNov 3, 2026, 4:20 PM EST
2.32 0.00 0.00%
After hours · Nov 3, 4:20 PM ET
2.29 Day range 2.40
2.29 52-week range 14.87
- YTD
- -81.47%
- 1 year
- -81.12%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 24.20 +943.1% upside
Now 2.32
- Target (low)
- 21.00
- Target (mean)
- 24.20
- Target (high)
- 27.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy1
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 6
- 2 months ago 6
- 3 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.416 | -0.53 – -0.35 | 0.00 | 0.0% | 0 | 0.0% | 5 |
| Next quarter | -0.43 | -0.49 – -0.36 | 0.00 | 0.0% | 0 | 0.0% | 4 |
| Current year | -2.23 | -3.18 – -1.43 | 0.00 | 0.0% | 0 | 0.0% | 4 |
| Next year | -2.13 | -3.14 – -1.45 | -2.23 | +4.4% | 0 | 0.0% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 13, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Sep 17, 2025 | Leerink Partners | Initiated | — | Outperform |
| Sep 15, 2025 | HC Wainwright & Co. | Initiated | — | Buy |
| Sep 4, 2025 | Oppenheimer | Initiated | — | Outperform |
| Aug 18, 2025 | Wedbush | Initiated | — | Outperform |